Twist Bioscience (TWST)

• Market cap: $5.64B
• 1 day: -3.23%
• 5 days: -6.36%
• 1 month: 33.75%
• 3 months: 89.19%
• 6 months: 138.28%
• Year to date: 179.84%
• 1 year: 135.61%
• 5 years: -27.26%
• 10 years: 547.43%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Employees: 979